Literature DB >> 8532772

Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine.

R Büttemeyer1, N F Jones, Z Min, U Rao.   

Abstract

One-hundred and fourteen limb transplantations have been performed across a major histoincompatibility barrier between donor ACI (RT1a) and recipient Lewis (RT1l) rats immunosuppressed with various dosages of FK-506 and cyclosporine. Three-hundred and thirty biopsy specimens from 64 animals have been evaluated histologically for signs of rejection. A new histologic grading system is introduced to classify the process of rejection in the component tissues (skin, muscle, bone, and articular cartilage) of a limb allograft. The results indicate that FK-506 is a more potent immunosuppressive agent than cyclosporine in preventing the rejection of the skin component of a limb transplant. With twice-weekly intermittent immunosuppression with FK-506, the rejection of muscle, bone, and cartilage can be prevented for an indefinite time, although all long-term surviving animals died at around 300 days, probably of graft-versus-host disease. Based on the histologic stages of rejection in the different tissues at the same point in time, it is evident that each component tissue of a limb transplant rejects over a different time period. This probably reflects a hierarchy of antigenicity, with skin being most antigenic, muscle being intermediate in antigenicity, and bone and cartilage being least antigenic. Although this grading system is not the ultimate solution, it may allow a more objective comparison of experimental limb transplantation in the future.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8532772     DOI: 10.1097/00006534-199601000-00023

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  13 in total

1.  Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model.

Authors:  Dimitra Kotsougiani; Caroline A Hundepool; Joost I Willems; Patricia Friedrich; Alexander Y Shin; Allen T Bishop
Journal:  J Vis Exp       Date:  2017-08-13       Impact factor: 1.355

2.  Fibroblast growth factor-2 and vascular endothelial growth factor mediated augmentation of angiogenesis and bone formation in vascularized bone allotransplants.

Authors:  Mikko Larsen; Wouter F Willems; Michael Pelzer; Patricia F Friedrich; Mahrokh Dadsetan; Allen T Bishop
Journal:  Microsurgery       Date:  2014-01-03       Impact factor: 2.425

3.  Living bone allotransplants survive by surgical angiogenesis alone: development of a novel method of composite tissue allotransplantation.

Authors:  Mikko Larsen; Michael Pelzer; Patricia F Friedrich; Christina M Wood; Allen T Bishop
Journal:  J Bone Joint Surg Am       Date:  2011-02-02       Impact factor: 5.284

4.  A modified vascularized whole knee joint allotransplantation model in the rat.

Authors:  Mikko Larsen; Patricia F Friedrich; Allen T Bishop
Journal:  Microsurgery       Date:  2010-10       Impact factor: 2.425

5.  Augmentation of surgical angiogenesis in vascularized bone allotransplants with host-derived a/v bundle implantation, fibroblast growth factor-2, and vascular endothelial growth factor administration.

Authors:  Mikko Larsen; Wouter F Willems; Michael Pelzer; Patricia F Friedrich; Michael J Yaszemski; Allen T Bishop
Journal:  J Orthop Res       Date:  2010-08       Impact factor: 3.494

6.  The characteristics of acute rejection after limb allotransplantation in rats--an experimental study.

Authors:  Hao Kang; Guangxiang Hong; Fabin Wang; Zhenbing Chen; Qishun Huang; Yuxiong Weng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

7.  Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.

Authors:  Fadi Issa; Joanna Hester; Ryoichi Goto; Satish N Nadig; Tim E Goodacre; Kathryn Wood
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

8.  Digital Joint Reconstruction with Osteotendinous Joint Allograft: Experimental Study in Rats.

Authors:  Martin Iglesias; Ángel Uriel Cruz-Reyes; Patricia Butrón; Ricardo Hernández-Agallo; Víctor Antonio Torres de la Barrera; Claudio Reyes-Montero; Marta Durand-Carbajal; Gonzalo Torres-Villalobos
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-04-20

9.  Vascularized composite allograft rejection is delayed by intrajejunal treatment with donor splenocytes without concomitant immunosuppressants.

Authors:  Christopher Glenn Wallace; Chia-Hung Yen; Hsiang-Chen Yang; Chun-Yen Lin; Ren-Chin Wu; Wei-Chao Huang; Jeng-Yee Lin; Fu-Chan Wei
Journal:  Clin Dev Immunol       Date:  2012-11-27

10.  Composite tissue allotransplantation immunology.

Authors:  Seok Chan Eun
Journal:  Arch Plast Surg       Date:  2013-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.